{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:35:01Z","timestamp":1791426901451,"version":"4.3.3"},"reference-count":84,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T00:00:00Z","timestamp":1513036800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC1305903"],"award-info":[{"award-number":["2016YFC1305903"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81373999"],"award-info":[{"award-number":["81373999"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81704130"],"award-info":[{"award-number":["81704130"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81774377"],"award-info":[{"award-number":["81774377"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002338","name":"Ministry of Education of the People's Republic of China","doi-asserted-by":"publisher","award":["NCET-13-0505"],"award-info":[{"award-number":["NCET-13-0505"]}],"id":[{"id":"10.13039\/501100002338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2016M590596"],"award-info":[{"award-number":["2016M590596"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2016M590598"],"award-info":[{"award-number":["2016M590598"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2016J05203"],"award-info":[{"award-number":["2016J05203"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2017J05139"],"award-info":[{"award-number":["2017J05139"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2016A030310371"],"award-info":[{"award-number":["2016A030310371"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003453","name":"Natural Science Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2017A030310643"],"award-info":[{"award-number":["2017A030310643"]}],"id":[{"id":"10.13039\/501100003453","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.neuropharm.2017.12.012","type":"journal-article","created":{"date-parts":[[2017,12,12]],"date-time":"2017-12-12T08:44:03Z","timestamp":1513068243000},"page":"223-237","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"special_numbering":"C","title":["Ginsenoside Rb1 confers neuroprotection via promotion of glutamate transporters in a mouse model of Parkinson's disease"],"prefix":"10.1016","volume":"131","author":[{"given":"Yun-Long","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Pan","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yan","family":"Dou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren-Gong","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Qiong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.12.012_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.brainresbull.2016.04.002","article-title":"Ginsenoside Rb1 as a neuroprotective agent: a review","volume":"125","author":"Ahmed","year":"2016","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib2","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1038\/npp.2015.26","article-title":"Astroglial glutamate transporter deficiency increases synaptic excitability and leads to pathological repetitive behaviors in mice","volume":"40","author":"Aida","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib3","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.pneurobio.2007.06.006","article-title":"Neurotensin receptor mechanisms and its modulation of glutamate transmission in the brain: relevance for neurodegenerative diseases and their treatment","volume":"83","author":"Antonelli","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib4","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1460-9568.2007.05979.x","article-title":"Oxidative stress on EAAC1 is involved in MPTP-induced glutathione depletion and motor dysfunction","volume":"27","author":"Aoyama","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nbd.2014.11.007","article-title":"Ginsenoside Rb1 inhibits fibrillation and toxicity of alpha-synuclein and disaggregates preformed fibrils","volume":"74","author":"Ardah","year":"2015","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib6","doi-asserted-by":"crossref","first-page":"4155","DOI":"10.1073\/pnas.94.8.4155","article-title":"Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance","volume":"94","author":"Arriza","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib7","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1523\/JNEUROSCI.14-09-05559.1994","article-title":"Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex","volume":"14","author":"Arriza","year":"1994","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.nbd.2014.01.011","article-title":"Progressive Parkinsonism by acute dysfunction of excitatory amino acid transporters in the rat substantia nigra","volume":"65","author":"Assous","year":"2014","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib9","doi-asserted-by":"crossref","first-page":"10529","DOI":"10.1523\/JNEUROSCI.1643-16.2016","article-title":"Neural stem cell transplantation induces stroke recovery by upregulating glutamate transporter GLT-1 in astrocytes","volume":"36","author":"Bacigaluppi","year":"2016","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib10","doi-asserted-by":"crossref","first-page":"S110","DOI":"10.1002\/ana.410440716","article-title":"Excitotoxicity and nitric oxide in Parkinson's disease pathogenesis","volume":"44","author":"Beal","year":"1998","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib11","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.expneurol.2003.12.012","article-title":"Differential expression and ser897 phosphorylation of striatal N-methyl-d-aspartate receptor subunit NR1 in animal models of Parkinson's disease","volume":"187","author":"Betarbet","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.expneurol.2012.04.017","article-title":"Influence of corticostriatal \u03b4-opioid receptors on abnormal involuntary movements induced by L-DOPA in hemiparkinsonian rats","volume":"236","author":"Billet","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib13","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neuro.2014.05.009","article-title":"Ceftriaxone mediated rescue of nigral oxidative damage and motor deficits in MPTP model of Parkinson's disease in rats","volume":"44","author":"Bisht","year":"2014","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib14","first-page":"65","article-title":"An update on the potential role of excitotoxicity in the pathogenesis of Parkinson's disease","volume":"25","author":"Blandini","year":"2010","journal-title":"Funct. Neurol."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib15","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson's disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib16","doi-asserted-by":"crossref","first-page":"3085","DOI":"10.1523\/JNEUROSCI.20-09-03085.2000","article-title":"Activation of group II metabotropic glutamate receptors inhibits synaptic excitation of the substantia Nigra pars reticulata","volume":"20","author":"Bradley","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib17","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1093\/brain\/awu329","article-title":"A\u00a0network centred on the inferior frontal cortex is critically involved in levodopa-induced dyskinesias","volume":"138","author":"Cerasa","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib18","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.parkreldis.2012.06.003","article-title":"Prefrontal thickening in PD with levodopa-induced dyskinesias: new evidence from cortical thickness measurement","volume":"19","author":"Cerasa","year":"2013","journal-title":"Park. Relat. Disord."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib19","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nrn3484","article-title":"Emerging roles of astrocytes in neural circuit development","volume":"14","author":"Clarke","year":"2013","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/cne.21852","article-title":"Downregulation of glial glutamate transporters after dopamine denervation in the striatum of 6-hydroxydopamine-lesioned rats","volume":"511","author":"Chung","year":"2008","journal-title":"J.\u00a0Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/375599a0","article-title":"An excitatory amino-acid transporter with properties of a ligand-gated chloride channel","volume":"375","author":"Fairman","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib22","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.neuroscience.2014.02.053","article-title":"Ceftriaxone alleviates early brain injury after subarachnoid hemorrhage by increasing excitatory amino acid transporter 2 expression via the PI3K\/Akt\/NF-kappaB signaling pathway","volume":"268","author":"Feng","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib23","doi-asserted-by":"crossref","first-page":"10221","DOI":"10.1523\/JNEUROSCI.1404-09.2009","article-title":"Presynaptic G-protein-coupled receptors dynamically modify vesicle fusion, synaptic cleft glutamate concentrations, and motor behavior","volume":"29","author":"Gerachshenko","year":"2009","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib24","doi-asserted-by":"crossref","first-page":"9159","DOI":"10.1523\/JNEUROSCI.0302-11.2011","article-title":"Nuclear factor-kappaB contributes to neuron-dependent induction of glutamate transporter-1 expression in astrocytes","volume":"31","author":"Ghosh","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib25","doi-asserted-by":"crossref","first-page":"943","DOI":"10.3892\/ijmm.2016.2663","article-title":"Propofol protects hippocampal neurons from apoptosis in ischemic brain injury by increasing GLT-1 expression and inhibiting the activation of NMDAR via the JNK\/Akt signaling pathway","volume":"38","author":"Gong","year":"2016","journal-title":"Int. J. Mol. Med."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11481-014-9569-6","article-title":"Potential neuroprotective activity of Ginseng in Parkinson's disease: a review","volume":"10","author":"Gonzalez-Burgos","year":"2015","journal-title":"J.\u00a0Neuroimmune Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib27","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.neulet.2016.01.048","article-title":"Neuroprotective effects of stemazole in the MPTP-induced acute model of Parkinson's disease: involvement of the dopamine system","volume":"616","author":"Guo","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib28","doi-asserted-by":"crossref","first-page":"34859","DOI":"10.1074\/jbc.M602568200","article-title":"Neural cell adhesion molecule-associated polysialic acid inhibits NR2B-containing N-methyl-D-aspartate receptors and prevents glutamate-induced cell death","volume":"281","author":"Hammond","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib29","doi-asserted-by":"crossref","first-page":"9736","DOI":"10.1523\/JNEUROSCI.3009-07.2007","article-title":"Extracellular glutamate concentration in hippocampal slice","volume":"27","author":"Herman","year":"2007","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib30","doi-asserted-by":"crossref","first-page":"8733","DOI":"10.1073\/pnas.96.15.8733","article-title":"Inhibition of uptake unmasks rapid extracellular turnover of glutamate of nonvesicular origin","volume":"96","author":"Jabaudon","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1038\/nprot.2006.342","article-title":"Protocol for the MPTP mouse model of Parkinson's disease","volume":"2","author":"Jackson-Lewis","year":"2007","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib32","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.coph.2014.10.008","article-title":"Excitatory amino acid transporters: recent insights into molecular mechanisms, novel modes of modulation and new therapeutic possibilities","volume":"20","author":"Jensen","year":"2015","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib33","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.neulet.2011.09.007","article-title":"Activation of group II metabotropic glutamate receptors induces long-term depression of excitatory synaptic transmission in the substantia nigra pars reticulata","volume":"504","author":"Johnson","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib34","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/360467a0","article-title":"Primary structure and functional characterization of a high-affinity glutamate transporter","volume":"360","author":"Kanai","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib35","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1111\/j.1460-9568.2005.04488.x","article-title":"Down-regulation of metabotropic glutamate receptor 1alpha in globus pallidus and substantia nigra of parkinsonian monkeys","volume":"22","author":"Kaneda","year":"2005","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib36","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","article-title":"Nuclear factor-kappaB in cancer development and progression","volume":"441","author":"Karin","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib37","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1007\/s11064-009-9939-2","article-title":"Comparative effects of acute or chronic administration of levodopa to 6-OHDA-lesioned rats on the expression and phosphorylation of N-methyl-D-aspartate receptor NR1 subunits in the striatum","volume":"34","author":"Kong","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib38","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/0006-8993(84)91189-2","article-title":"The cortico-nigral projection: reduced glutamate content in the substantia nigra following frontal cortex ablation in the rat","volume":"322","author":"Kornhuber","year":"1984","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib39","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0197-0186(03)00080-9","article-title":"Gene expression of glutamate receptors GluR1 and NR1 is differentially modulated in striatal neurons in rats after 6-hydroxydopamine lesion","volume":"43","author":"Lai","year":"2003","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib40","doi-asserted-by":"crossref","first-page":"13116","DOI":"10.1074\/jbc.M707697200","article-title":"Mechanism of ceftriaxone induction of excitatory amino acid transporter-2 expression and glutamate uptake in primary human astrocytes","volume":"283","author":"Lee","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib41","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1113\/jphysiol.2006.123570","article-title":"Tonic activation of NMDA receptors by ambient glutamate of non-synaptic origin in the rat hippocampus","volume":"580","author":"Le Meur","year":"2007","journal-title":"J.\u00a0Physiol."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib42","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1021\/cn200072h","article-title":"Ceftriaxone ameliorates motor deficits and protects dopaminergic neurons in 6-hydroxydopamine-lesioned rats","volume":"3","author":"Leung","year":"2012","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib43","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1038\/70978","article-title":"Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease","volume":"5","author":"Liberatore","year":"1999","journal-title":"Nat. Med."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib44","doi-asserted-by":"crossref","first-page":"4887","DOI":"10.1523\/JNEUROSCI.5828-11.2012","article-title":"G-protein-coupled receptor 30 mediates rapid neuroprotective effects of estrogen via depression of NR2B-containing NMDA receptors","volume":"32","author":"Liu","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib45","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.phymed.2012.02.006","article-title":"Protective effect of extract of Acanthopanax senticosus Harms on dopaminergic neurons in Parkinson's disease mice","volume":"19","author":"Liu","year":"2012","journal-title":"Phytomedicine"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib46","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.1007\/s11064-012-0726-0","article-title":"NR2B-containing NMDA receptors expression and their relationship to apoptosis in hippocampus of Alzheimer's disease-like rats","volume":"37","author":"Liu","year":"2012","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib47","doi-asserted-by":"crossref","first-page":"4674","DOI":"10.1523\/JNEUROSCI.19-11-04674.1999","article-title":"Relationships between the prefrontal cortex and the basal ganglia in the rat: physiology of the cortico-nigral circuits","volume":"19","author":"Maurice","year":"1999","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib48","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1111\/ejn.12205","article-title":"Striatal glutamate induces retrograde excitotoxicity and neuronal degeneration of intralaminar thalamic nuclei: their potential relevance for Parkinson's disease","volume":"38","author":"Morales","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib49","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neuroscience.2014.05.032","article-title":"Glutamate neurons within the midbrain dopamine regions","volume":"282","author":"Morales","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib50","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1016\/j.neuroscience.2008.01.046","article-title":"Stereological estimates of dopaminergic, GABAergic and glutamatergic neurons in the ventral tegmental area, substantia nigra and retrorubral field in the rat","volume":"152","author":"Nair-Roberts","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib51","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0014-2999(02)01495-4","article-title":"The medial prefrontal cortex mediates 3-methoxytyramine-induced behavioural changes in rat","volume":"442","author":"Nakazato","year":"2002","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib52","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1152\/jn.91138.2008","article-title":"Glutamate transporters prevent excessive activation of NMDA receptors and extrasynaptic glutamate spillover in the spinal dorsal horn","volume":"101","author":"Nie","year":"2009","journal-title":"J.\u00a0Neurophysiol."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib53","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.neuron.2015.12.038","article-title":"Pathway-specific remodeling of thalamostriatal synapses in parkinsonian mice","volume":"89","author":"Parker","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib54","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1212\/WNL.0000000000003634","article-title":"Natural course of mild cognitive impairment in Parkinson disease: a 5-year population-based study","volume":"88","author":"Pedersen","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib55","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1002\/jnr.23638","article-title":"Executive function deficits and glutamatergic protein alterations in a progressive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's disease","volume":"93","author":"Pflibsen","year":"2015","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib56","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/360464a0","article-title":"Cloning and expression of a rat brain L-glutamate transporter","volume":"360","author":"Pines","year":"1992","journal-title":"Nature"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2017.12.012_bib57","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuropharm.2005.03.006","article-title":"Metabotropic glutamate receptor 2 modulates excitatory synaptic transmission in the rat globus pallidus","volume":"49","author":"Poisik","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib58","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00702-003-0063-1","article-title":"Ginsenosides Rb1 and Rg1 effects on survival and neurite growth of MPP+-affected mesencephalic dopaminergic cells","volume":"111","author":"Radad","year":"2004","journal-title":"J.\u00a0Neural. Transm."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib59","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0006-8993(90)90952-8","article-title":"Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological data","volume":"518","author":"Robledo","year":"1990","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib60","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nature03180","article-title":"Beta-lactam antibiotics offer neuroprotection by increasing glutamate transporter expression","volume":"433","author":"Rothstein","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib61","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.expneurol.2012.01.012","article-title":"Transient striatal GLT-1 blockade increases EAAC1 expression, glutamate reuptake, and decreases tyrosine hydroxylase phosphorylation at ser(19)","volume":"234","author":"Salvatore","year":"2012","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib62","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/NEN.0b013e31819cabe4","article-title":"Metabotropic glutamate receptor II in the brains of Parkinsonian patients","volume":"68","author":"Samadi","year":"2009","journal-title":"J.\u00a0Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib63","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(04)16305-8","article-title":"Parkinson's disease","volume":"363","author":"Samii","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib64","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s12031-014-0303-x","article-title":"Escin, a novel triterpene, mitigates chronic MPTP\/p-induced dopaminergic toxicity by attenuating mitochondrial dysfunction, oxidative stress, and apoptosis","volume":"55","author":"Selvakumar","year":"2015","journal-title":"J.\u00a0Mol. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib65","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1093\/cercor\/bhs342","article-title":"Anatomic and molecular development of corticostriatal projection neurons in mice","volume":"24","author":"Sohur","year":"2014","journal-title":"Cerebr. Cortex"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib66","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/BF01345245","article-title":"Role of glutamate in neurodegeneration of dopamine neurons in several animal models of parkinsonism","volume":"14","author":"Sonsalla","year":"1998","journal-title":"Amino Acids"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib67","doi-asserted-by":"crossref","first-page":"10955","DOI":"10.1073\/pnas.89.22.10955","article-title":"Structure, expression, and functional analysis of a Na(+)-dependent glutamate\/aspartate transporter from rat brain","volume":"89","author":"Storck","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib68","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neuint.2014.04.007","article-title":"Glutamate transporter control of ambient glutamate levels","volume":"73","author":"Sun","year":"2014","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib69","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1038\/sj.npp.1301501","article-title":"KATP channel openers facilitate glutamate uptake by GluTs in rat primary cultured astrocytes","volume":"33","author":"Sun","year":"2008","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib70","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1002\/jnr.22669","article-title":"Sex- and brain region-specific role of cytochrome c oxidase in 1-methyl-4-phenylpyridinium-mediated astrocyte vulnerability","volume":"89","author":"Sundar Boyalla","year":"2011","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib71","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.neures.2005.11.002","article-title":"Roles of glial glutamate transporters in shaping EPSCs at the climbing fiber-Purkinje cell synapses","volume":"54","author":"Takatsuru","year":"2006","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib72","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/S0306-4522(96)00545-3","article-title":"In situ detection of apoptotic nuclei in the substantia nigra compacta of 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine- treated mice using terminal deoxynucleotidyl transferase labelling and acridine orange staining","volume":"77","author":"Tatton","year":"1997","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib73","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1073\/pnas.0837397100","article-title":"Cyclooxygenase-2 is instrumental in Parkinson's disease neurodegeneration","volume":"100","author":"Teismann","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib74","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/j.1749-6632.2003.tb07471.x","article-title":"Apoptosis inducing factor and PARP-mediated injury in the MPTP mouse model of Parkinson's disease","volume":"991","author":"Wang","year":"2009","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib75","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.neuron.2012.03.017","article-title":"Whole-brain mapping of direct inputs to midbrain dopamine neurons","volume":"74","author":"Watabe-Uchida","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2017.12.012_bib76","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1460-9568.2006.05263.x","article-title":"Glutamatergic neurons are present in the rat ventral tegmental area","volume":"25","author":"Yamaguchi","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib77","doi-asserted-by":"crossref","first-page":"8476","DOI":"10.1523\/JNEUROSCI.1598-11.2011","article-title":"Mesocorticolimbic glutamatergic pathway","volume":"31","author":"Yamaguchi","year":"2011","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib78","doi-asserted-by":"crossref","first-page":"3602","DOI":"10.1111\/ejn.12359","article-title":"Glutamate neurons in the substantia nigra compacta and retrorubral field","volume":"38","author":"Yamaguchi","year":"2013","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib79","doi-asserted-by":"crossref","first-page":"152","DOI":"10.3389\/fphar.2013.00152","article-title":"Ginsenoside Rd promotes glutamate clearance by up-regulating glial glutamate transporter GLT-1 via PI3K\/AKT and ERK1\/2 pathways","volume":"4","author":"Zhang","year":"2013","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib80","doi-asserted-by":"crossref","first-page":"e2574","DOI":"10.1038\/cddis.2016.454","article-title":"Regulation of glutamate transporter trafficking by Nedd4-2 in a Parkinson's disease model","volume":"8","author":"Zhang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib81","doi-asserted-by":"crossref","first-page":"e2611","DOI":"10.1038\/cddis.2016.491","article-title":"Rapamycin upregulates glutamate transporter and IL-6 expression in astrocytes in a mouse model of Parkinson's disease","volume":"8","author":"Zhang","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib82","doi-asserted-by":"crossref","first-page":"8941327","DOI":"10.1155\/2016\/8941327","article-title":"Recent advance in the relationship between excitatory amino acid transporters and Parkinson's disease","volume":"2016","author":"Zhang","year":"2016","journal-title":"Neural Plast."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib83","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s12035-014-8845-z","article-title":"Ceftriaxone protects astrocytes from MPP(+) via suppression of NF-kappaB\/JNK\/c-Jun signaling","volume":"52","author":"Zhang","year":"2015","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.neuropharm.2017.12.012_bib84","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1016\/j.neurobiolaging.2015.04.005","article-title":"Ceftriaxone ameliorates tau pathology and cognitive decline via restoration of glial glutamate transporter in a mouse model of Alzheimer's disease","volume":"36","author":"Zumkehr","year":"2015","journal-title":"Neurobiol. Aging"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817306019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817306019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,16]],"date-time":"2022-06-16T01:54:34Z","timestamp":1655344474000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817306019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":84,"alternative-id":["S0028390817306019"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.12.012","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ginsenoside Rb1 confers neuroprotection via promotion of glutamate transporters in a mouse model of Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}